Search Results

search
KRTL HOLDINGS SMALL Black Text.png
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 24, 2025 09:00 ET | KRTL Holding Group
Lakewood, CO, March 24, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL), a diversified holding company operating through its subsidiaries KRTL Biotech, Inc. and KRTL International...
MBRX_Logo.png
Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update
March 24, 2025 07:05 ET | Moleculin Biotech, Inc.
– Continued progress in pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) toward first subject treated, on track to take place in the first quarter of 2025 – Multiple subjects currently...
22157.jpg
Pharma 4.0 Business Research Report 2024-2030: Growing Prevalence of Complex Biologics and Biosimilars Driving Expansion Through AI-Driven Analytics
March 19, 2025 08:22 ET | Research and Markets
Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Pharma 4.0 - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Pharma 4 was valued...
MBRX_Logo.png
Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast
March 19, 2025 08:05 ET | Moleculin Biotech, Inc.
HOUSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates...
22157.jpg
International Directory of Pharmaceutical Companies 2025: New Pharma Industry Directory Covers 200+ Countries, 20,000+ Companies & Key Executives
February 26, 2025 12:33 ET | Research and Markets
Dublin, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The "International Directory of Pharmaceutical Companies 2025" has been added to ResearchAndMarkets.com's offering. The International Directory of...
22157.jpg
2025 Directory of Top 1,000 Pharmaceutical Companies: Business Profiles of Major International Pharma and Biotech Companies
February 26, 2025 11:49 ET | Research and Markets
Dublin, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The "Top 1000 Major Pharmaceutical Companies 2025" directory has been added to ResearchAndMarkets.com's offering. Essential for those doing business in...
22157.jpg
USA Pharmaceutical Directory 2025: Access Details for Over 4,000 Pharmaceutical Companies and 8,000+ Executives Working in the Pharma Industry
February 25, 2025 11:01 ET | Research and Markets
Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The "USA Pharmaceutical Directory 2025" has been added to ResearchAndMarkets.com's offering. The USA Pharmaceutical Directory is one of the most...
22157.jpg
Pharma Supply Chain & Security Conference 2025: Focus on Optimizing your Challenges to Ensure an Agile, Responsive, Streamlined and Secured Supply Chain (London, United Kingdom - March 12-13, 2025)
February 20, 2025 05:29 ET | Research and Markets
Dublin, Feb. 20, 2025 (GLOBE NEWSWIRE) -- The "Pharma Supply Chain & Security World 2025" conference has been added to ResearchAndMarkets.com's offering. The Annual Pharma Supply Chain &...
Logo.jpg
LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 11, 2025 08:42 ET | Lixte Biotechnology Holdings, Inc.
PASADENA, CALIF., Feb. 11, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced...
image.png
Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones
February 04, 2025 09:25 ET | Jupiter Neurosciences, Inc.
Jupiter, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented...